Shukra Pharmaceuticals Ltd

In connection with our earlier correspondence dated 4th January 2025 wherein the Company intimated about the Board meeting scheduled to be held on Thursday 9th January 2025 we would like to inform the Exchange and all Stakeholders that certain matters including the matters relating to Right Issue which were originally scheduled to be transacted at the ensuing Board meeting have now been deferred for being considered by the Board.The Company will intimate in due course and in accordance with the SEBI LODR regulations about the date of the Board meeting at which the offer and issue of equity shares of the Company will be considered.